Drug
Gal 101
Gal 101: highest development phase Phase 2, developed by Galimedix Therapeutics Inc. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Galimedix Therapeutics Inc
Trials
| Drug | Phase | Indication |
|---|---|---|
| GAL-101 NCT06659549 | Phase 2 | Geographic Atrophy of the Macula |
Latest
No recent events.
Follow Gal 101 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.